Vaxum, LLC

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 100.0

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 32

Loading Chart...

2 inventors (with patents filed for the assignee):

Albert B Deisseroth (5 out of 32 patents)

Lixin Zhang (5 out of 5 patents)

Albert B Deisserroth (0 patent)

5 patents: Sort by Forward Citations

1. 11027006 - Adenoviral vector vaccine (2021-06-08),

2. 9458221 - Adenoviral expression vector encoding a CD40L fusion protein (2016-10-04),

3. 8540979 - Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein (2013-09-24),

4. 8236295 - Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses (2012-08-07),

5. 8119117 - Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity (2012-02-21),

Company Overview

Vaxum, LLC is a leading provider of innovative software solutions for businesses. With a focus on cutting-edge technologies such as artificial intelligence and machine learning, Vaxum helps companies optimize their operations and improve efficiency. From custom software development to data analytics, Vaxum offers a wide range of services to meet the unique needs of each client.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#6 in Warrenton, VA

#926 in Virginia

#51,669 in US

Warrenton, VA, United States of America

Vaxum, LLC

Forward Citations = 32

2 inventors:

Albert B Deisseroth (5 out of 32 patents)

Lixin Zhang (5 out of 5 patents)

Albert B Deisserroth (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vaxum, LLC. Retrieved from https://idiyas.com/company/vaxum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]